 PROSPECTIVE EVALUATION AMONG PATIENTS INFECTED BY HIV 1 IN VIROLOGICAL FAILURE OWING TO LACK OF COMPLIANCE, OF THE BENEFIT IN TERMS OF COMPLIANCE OF AN OPTIMISED ANTIRETROVIRAL TREATMENT WITH ENFUVIRTIDE FUZEON ASSOCIATED WITH TWO ACTIVE MOLECULES: 